STOCK TITAN
  1. Home
  2. Sec-filings
  3. BMEA
  4. [SCHEDULE 13D/A] Biomea Fusion, Inc. SEC Filing

[SCHEDULE 13D/A] Biomea Fusion, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

This amendment reports that a Cormorant investment group and director Bihua Chen together hold a meaningful minority stake in Biomea Fusion, Inc. The filing discloses group-wide shared voting and dispositive power over 3,570,872 shares, equal to 5.15% of common stock, and that Ms. Chen separately holds or controls an additional 110,792 shares and options exercisable within 60 days, bringing her aggregate economic interest to 3,681,664 shares or 5.31% of the company.

The percentage calculations use a post-offering share count of 69,322,377 common shares as stated in the filing materials. The filing also notes there were no transactions in the issuer's securities by the reporting persons during the sixty-day period before this statement, and it updates identity, citizenship, and source-of-funds information for the reporting entities.

Questo emendamento riporta che un gruppo di investimento Cormorant e il direttore Bihua Chen possiedono insieme una partecipazione di minoranza significativa in Biomea Fusion, Inc. La presentazione rivela potere di voto e dispositivi a livello di gruppo su 3,570,872 azioni, pari al 5.15% del capitale sociale ordinario, e che la signora Chen detiene o controlla separatamente ulteriori 110,792 azioni e opzioni esercitabili entro 60 giorni, portando la sua partecipazione economica aggregata a 3,681,664 azioni o 5.31% della società.

Il calcolo delle percentuali utilizza un conteggio post-offerta di 69,322,377 azioni ordinarie come indicato nei materiali di deposito. Il fascicolo segnala anche che non ci sono state transazioni nelle securities dell'emittente da parte delle persone che hanno presentato la dichiarazione durante i sessanta giorni precedenti, e aggiorna le informazioni su identità, cittadinanza e fonte dei fondi per gli enti segnalanti.

Esta enmienda informa que un grupo de inversión Cormorant y el director Bihua Chen poseen conjuntamente una participación minoritaria significativa en Biomea Fusion, Inc. La presentación divulga poder de voto y disposición a nivel de grupo sobre 3,570,872 acciones, equivalente al 5.15% del capital social común, y que la Sra. Chen posee o controla por separado otras 110,792 acciones y opciones exercitables dentro de 60 días, elevando su interés económico agregado a 3,681,664 acciones o 5.31% de la empresa.

Los cálculos de porcentaje utilizan un recuento de acciones posterior a la oferta de 69,322,377 acciones comunes según se indica en los materiales de presentación. El expediente también señala que no hubo transacciones en valores del emisor por parte de las personas que reportan durante el período de sesenta días anterior a esta declaración, y actualiza la identidad, la ciudadanía y la fuente de fondos de las entidades reportantes.

이 개정안은 Cormorant 투자 그룹과 이사 Bihua Chen이 함께 Biomea Fusion, Inc.에 의미 있는 소액 지분을 보유하고 있음을 보고합니다. 제출 문서는 그룹 전체에 걸친 공동 의결 및 처분 권한을 3,570,872주에 대해 명시하며, 이는 보통주의 5.15%에 해당합니다. 또한 Chen 여사는 별도로 추가로 110,792주를 보유하거나 보유하고 있으며 60일 이내 행사 가능한 옵션도 가지고 있어 그녀의 총 경제적 이해가 3,681,664주 또는 5.31%의 회사 지분으로 증가합니다.

백분율 계산은 증권 발행 직후의 일반주 수 69,322,377주를 사용합니다. 제출 문서에는 또한 이 보고인들에 의한 지난 60일 동안 발행자 증권에 대한 거래가 없었다는 점이 언급되며 보고 주체들의 신원, 시민권 및 자금 출처 정보도 업데이트됩니다.

Cette modification indique qu'un groupe d'investissement Cormorant et le directeur Bihua Chen détiennent ensemble une participation minoritaire importante dans Biomea Fusion, Inc. Le dépôt révèle un pouvoir de vote et de disposition au niveau du groupe sur 3 570 872 actions, équivalant à 5,15% du capital social ordinaire, et que Mme Chen détient ou contrôle séparément des 110 792 actions supplémentaires et des options exerçables dans 60 jours, portant son intérêt économique agrégé à 3 681 664 actions ou 5,31% de la société.

Les calculs en pourcentage utilisent un nombre d'actions ordinaires post-offre de 69 322 377 comme indiqué dans les documents du dépôt. Le dossier précise également qu'il n'y a eu aucune transaction dans les valeurs de l'émetteur par les personnes dépositaires pendant la période de soixante jours précédant cette déclaration, et met à jour les informations d'identité, de citoyenneté et de source de fonds des entités déclarantes.

Diese Änderung berichtet, dass eine Cormorant-Investmentgruppe und der Direktor Bihua Chen zusammen eine bedeutende Minderheitsbeteiligung an Biomea Fusion, Inc. halten. Die Einreichung offenbart gruppenweites gemeinsames Stimm- und Verfügungsrecht über 3,570,872 Aktien, entsprechend 5,15% des Stammkapitals, und dass Frau Chen separat weitere 110,792 Aktien hält oder kontrolliert und Optionen, die innerhalb von 60 Tagen ausübbar sind, wodurch ihr aggregiertes wirtschaftliches Eigentum auf 3,681,664 Aktien oder 5,31% des Unternehmens ansteigt.

Die Prozentberechnungen verwenden eine nach der Offerierung verbleibende Anzahl von 69,322,377 Stammaktien, wie in den Einreichungsmaterialien angegeben. Die Einreichung weist außerdem darauf hin, dass es in den sechzig Tagen vor dieser Erklärung keine Transaktionen in Wertpapieren des Emittenten durch die meldepflichtigen Personen gab, und sie aktualisiert auch Identität, Staatsangehörigkeit und Herkunft der Mittel der meldenden Einheiten.

تُبيّن هذه المَسودة أن مجموعة استثمارية تُدعى Cormorant ومديرها Bihua Chen يملكان معاً حصة الأقلية الهامة في Biomea Fusion, Inc. تكشف الإيداع عن سلطة التصويت والتصرف المشتركة على مستوى المجموعة على 3,570,872 سهماً، ما يعادل 5.15% من الأسهم العادية، وأن السيدة تشن تمتلك أو تتحكم بشكل منفصل في إضافية قدرها 110,792 سهماً وخيارات قابلة لتنفيـزها خلال 60 يوماً، مما يجعل إجمالي مصلحتها الاقتصادية يصل إلى 3,681,664 سهماً أو 5.31% من الشركة.

يستخدم حساب النسب المئوية عدد الأسهم العادية بعد العرض البالغ 69,322,377 كما ورد في مواد الإيداع. كما تشير الوثيقة إلى أنه لم تُجرَ أي معاملات في أوراق الشركة من قبل الأشخاص المبلغين خلال فترة الستين يوماً السابقة لهذا البيان، وتقوم بتحديث معلومات الهوية والجنسية ومصدر الأموال للجهات المبلغ عنها.

本修正案报告，Cormorant 投资集团及董事 Bihua Chen 共同持有 Biomea Fusion, Inc. 的显著少数股权。备案显示，集团层面的共同投票与处置权覆盖 3,570,872 股普通股，等于 5.15%；陈女士另单独持有或控制额外的 110,792 股，以及可在 60 days 内行使的期权，使她的总经济权益增至 3,681,664 股，约占公司 5.31%。

百分比计算使用备案材料所述的发行后普通股总数 69,322,377 股。备案还指出，在本声明之前的六十日内，报告人对发行人证券没有任何交易，并更新报告主体的身份、国籍和资金来源信息。

Positive
  • Aggregate stake of 5.31% signals a material, disclosed position by an investor and a director
  • Clear breakdown of shared vs. sole voting/dispositive power improves transparency for shareholders
  • No transactions in the prior 60 days indicates holdings were stable at the time of this filing
Negative
  • None.

Insights

Cormorant and director holdings cross the 5% threshold, creating a visible shareholder block.

The group reports shared control of 3,570,872 shares (5.15%) while the director's aggregate holdings, including options exercisable within 60 days, total 3,681,664 shares (5.31%), calculated on a stated outstanding base of 69,322,377 shares.

This level of disclosed ownership is large enough to matter for governance and votes on routine corporate actions; the filing also confirms no transactions in the prior sixty days. Watch for any subsequent amendments or open-market activity that change these percentages near corporate votes or financing actions.

Questo emendamento riporta che un gruppo di investimento Cormorant e il direttore Bihua Chen possiedono insieme una partecipazione di minoranza significativa in Biomea Fusion, Inc. La presentazione rivela potere di voto e dispositivi a livello di gruppo su 3,570,872 azioni, pari al 5.15% del capitale sociale ordinario, e che la signora Chen detiene o controlla separatamente ulteriori 110,792 azioni e opzioni esercitabili entro 60 giorni, portando la sua partecipazione economica aggregata a 3,681,664 azioni o 5.31% della società.

Il calcolo delle percentuali utilizza un conteggio post-offerta di 69,322,377 azioni ordinarie come indicato nei materiali di deposito. Il fascicolo segnala anche che non ci sono state transazioni nelle securities dell'emittente da parte delle persone che hanno presentato la dichiarazione durante i sessanta giorni precedenti, e aggiorna le informazioni su identità, cittadinanza e fonte dei fondi per gli enti segnalanti.

Esta enmienda informa que un grupo de inversión Cormorant y el director Bihua Chen poseen conjuntamente una participación minoritaria significativa en Biomea Fusion, Inc. La presentación divulga poder de voto y disposición a nivel de grupo sobre 3,570,872 acciones, equivalente al 5.15% del capital social común, y que la Sra. Chen posee o controla por separado otras 110,792 acciones y opciones exercitables dentro de 60 días, elevando su interés económico agregado a 3,681,664 acciones o 5.31% de la empresa.

Los cálculos de porcentaje utilizan un recuento de acciones posterior a la oferta de 69,322,377 acciones comunes según se indica en los materiales de presentación. El expediente también señala que no hubo transacciones en valores del emisor por parte de las personas que reportan durante el período de sesenta días anterior a esta declaración, y actualiza la identidad, la ciudadanía y la fuente de fondos de las entidades reportantes.

이 개정안은 Cormorant 투자 그룹과 이사 Bihua Chen이 함께 Biomea Fusion, Inc.에 의미 있는 소액 지분을 보유하고 있음을 보고합니다. 제출 문서는 그룹 전체에 걸친 공동 의결 및 처분 권한을 3,570,872주에 대해 명시하며, 이는 보통주의 5.15%에 해당합니다. 또한 Chen 여사는 별도로 추가로 110,792주를 보유하거나 보유하고 있으며 60일 이내 행사 가능한 옵션도 가지고 있어 그녀의 총 경제적 이해가 3,681,664주 또는 5.31%의 회사 지분으로 증가합니다.

백분율 계산은 증권 발행 직후의 일반주 수 69,322,377주를 사용합니다. 제출 문서에는 또한 이 보고인들에 의한 지난 60일 동안 발행자 증권에 대한 거래가 없었다는 점이 언급되며 보고 주체들의 신원, 시민권 및 자금 출처 정보도 업데이트됩니다.

Cette modification indique qu'un groupe d'investissement Cormorant et le directeur Bihua Chen détiennent ensemble une participation minoritaire importante dans Biomea Fusion, Inc. Le dépôt révèle un pouvoir de vote et de disposition au niveau du groupe sur 3 570 872 actions, équivalant à 5,15% du capital social ordinaire, et que Mme Chen détient ou contrôle séparément des 110 792 actions supplémentaires et des options exerçables dans 60 jours, portant son intérêt économique agrégé à 3 681 664 actions ou 5,31% de la société.

Les calculs en pourcentage utilisent un nombre d'actions ordinaires post-offre de 69 322 377 comme indiqué dans les documents du dépôt. Le dossier précise également qu'il n'y a eu aucune transaction dans les valeurs de l'émetteur par les personnes dépositaires pendant la période de soixante jours précédant cette déclaration, et met à jour les informations d'identité, de citoyenneté et de source de fonds des entités déclarantes.

Diese Änderung berichtet, dass eine Cormorant-Investmentgruppe und der Direktor Bihua Chen zusammen eine bedeutende Minderheitsbeteiligung an Biomea Fusion, Inc. halten. Die Einreichung offenbart gruppenweites gemeinsames Stimm- und Verfügungsrecht über 3,570,872 Aktien, entsprechend 5,15% des Stammkapitals, und dass Frau Chen separat weitere 110,792 Aktien hält oder kontrolliert und Optionen, die innerhalb von 60 Tagen ausübbar sind, wodurch ihr aggregiertes wirtschaftliches Eigentum auf 3,681,664 Aktien oder 5,31% des Unternehmens ansteigt.

Die Prozentberechnungen verwenden eine nach der Offerierung verbleibende Anzahl von 69,322,377 Stammaktien, wie in den Einreichungsmaterialien angegeben. Die Einreichung weist außerdem darauf hin, dass es in den sechzig Tagen vor dieser Erklärung keine Transaktionen in Wertpapieren des Emittenten durch die meldepflichtigen Personen gab, und sie aktualisiert auch Identität, Staatsangehörigkeit und Herkunft der Mittel der meldenden Einheiten.




If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Cormorant Global Healthcare Master Fund, LP
Signature:/s/ CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP By: Cormorant Global Healthcare GP, LLC, its General Partner
Name/Title:By: Bihua Chen, Managing Member
Date:10/10/2025
Cormorant Global Healthcare GP, LLC
Signature:/s/ Bihua Chen
Name/Title:By: Bihua Chen, Managing Member
Date:10/10/2025
Cormorant Private Healthcare Fund III LP
Signature:/s/ CORMORANT PRIVATE HEALTHCARE FUND III, LP By: Cormorant Private Healthcare GP III, LLC, its General Partner
Name/Title:By: Bihua Chen, Managing Member
Date:10/10/2025
Cormorant Private Healthcare GP III, LLC
Signature:/s/ Bihua Chen
Name/Title:By: Bihua Chen, Managing Member
Date:10/10/2025
Cormorant Asset Management, LP
Signature:/s/ CORMORANT ASSET MANAGEMENT, LP By: Cormorant Asset Management GP, LLC, its General Partner
Name/Title:By: Bihua Chen, Managing Member
Date:10/10/2025
Chen Bihua
Signature:/s/ Bihua Chen
Name/Title:Bihua Chen
Date:10/10/2025

Source: View Original Filing on SEC EDGAR

FAQ

What stake does Cormorant hold in Biomea Fusion (BMEA)?

Cormorant entities report shared voting and dispositive power over 3,570,872 shares, equal to 5.15% of outstanding common stock.

What is Bihua Chen's total reported ownership in BMEA?

Bihua Chen's aggregate interest is 3,681,664 shares, representing 5.31%, including shares she may receive upon option exercise within 60 days.

What share count was used to calculate the percentages?

Percentages are calculated using a post-offering share count of 69,322,377 common shares as stated in the filing materials.

Did the reporting persons trade BMEA shares in the last 60 days?

No. The filing states the reporting persons did not engage in any transactions during the sixty-day period prior to this statement.

Does the filing change who controls the reported shares?

The filing clarifies shared voting and dispositive power across the Cormorant entities and confirms Ms. Chen's separate sole voting/dispositive power over 110,792 shares.
Stock BMEA logo
Biomea Fusion, Inc.

NASDAQ:BMEA

BMEA Rankings

#4695 Ranked by Market Cap
N/A Ranked by Dividends

BMEA Latest News

Oct 7, 2025
Biomea Fusion Announces Pricing of Public Offering of Securities
Oct 6, 2025
Biomea Fusion Announces Proposed Public Offering of Securities
Oct 6, 2025
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
Oct 1, 2025
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Sep 16, 2025
Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

BMEA Latest SEC Filings

Oct 7, 2025
[8-K] Biomea Fusion, Inc. Reports Material Event
Oct 7, 2025
[424B5] Biomea Fusion, Inc. Prospectus Supplement (Debt Securities)
Oct 6, 2025
[424B5] Biomea Fusion, Inc. Prospectus Supplement (Debt Securities)
Oct 6, 2025
[8-K] Biomea Fusion, Inc. Reports Material Event
Aug 13, 2025
[SCHEDULE 13G/A] Biomea Fusion, Inc. SEC Filing

BMEA Stock Data

126.56M
53.87M
9.47%
48.39%
13.52%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN CARLOS